Global Swine Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 95

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans.

According to our (Global Info Research) latest study, the global Swine Flu Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Swine Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Swine Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Swine Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Swine Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Swine Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Flu Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, CSL Limited, Zydus Cadila, AstraZeneca and GlaxoSmithKline, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Swine Flu Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Intradermal Vaccination
    Intramuscular Vaccination
    Subcutaneous Vaccination
    Others

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Clinic And Vaccination Centers

Major players covered
    Novartis
    CSL Limited
    Zydus Cadila
    AstraZeneca
    GlaxoSmithKline
    Sanofi
    Baxter
    Sinovac Biotech

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Swine Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Flu Vaccine, with price, sales, revenue and global market share of Swine Flu Vaccine from 2018 to 2023.
Chapter 3, the Swine Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Flu Vaccine.
Chapter 14 and 15, to describe Swine Flu Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Swine Flu Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Swine Flu Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Intradermal Vaccination
        1.3.3 Intramuscular Vaccination
        1.3.4 Subcutaneous Vaccination
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Swine Flu Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
        1.4.5 Clinic And Vaccination Centers
    1.5 Global Swine Flu Vaccine Market Size & Forecast
        1.5.1 Global Swine Flu Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Swine Flu Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Swine Flu Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Swine Flu Vaccine Product and Services
        2.1.4 Novartis Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novartis Recent Developments/Updates
    2.2 CSL Limited
        2.2.1 CSL Limited Details
        2.2.2 CSL Limited Major Business
        2.2.3 CSL Limited Swine Flu Vaccine Product and Services
        2.2.4 CSL Limited Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Limited Recent Developments/Updates
    2.3 Zydus Cadila
        2.3.1 Zydus Cadila Details
        2.3.2 Zydus Cadila Major Business
        2.3.3 Zydus Cadila Swine Flu Vaccine Product and Services
        2.3.4 Zydus Cadila Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Zydus Cadila Recent Developments/Updates
    2.4 AstraZeneca
        2.4.1 AstraZeneca Details
        2.4.2 AstraZeneca Major Business
        2.4.3 AstraZeneca Swine Flu Vaccine Product and Services
        2.4.4 AstraZeneca Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AstraZeneca Recent Developments/Updates
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Swine Flu Vaccine Product and Services
        2.5.4 GlaxoSmithKline Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 GlaxoSmithKline Recent Developments/Updates
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi Swine Flu Vaccine Product and Services
        2.6.4 Sanofi Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Sanofi Recent Developments/Updates
    2.7 Baxter
        2.7.1 Baxter Details
        2.7.2 Baxter Major Business
        2.7.3 Baxter Swine Flu Vaccine Product and Services
        2.7.4 Baxter Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Baxter Recent Developments/Updates
    2.8 Sinovac Biotech
        2.8.1 Sinovac Biotech Details
        2.8.2 Sinovac Biotech Major Business
        2.8.3 Sinovac Biotech Swine Flu Vaccine Product and Services
        2.8.4 Sinovac Biotech Swine Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sinovac Biotech Recent Developments/Updates

3 Competitive Environment: Swine Flu Vaccine by Manufacturer
    3.1 Global Swine Flu Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Swine Flu Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Swine Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Swine Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Swine Flu Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Swine Flu Vaccine Manufacturer Market Share in 2022
    3.5 Swine Flu Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Swine Flu Vaccine Market: Region Footprint
        3.5.2 Swine Flu Vaccine Market: Company Product Type Footprint
        3.5.3 Swine Flu Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Swine Flu Vaccine Market Size by Region
        4.1.1 Global Swine Flu Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Swine Flu Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Swine Flu Vaccine Average Price by Region (2018-2029)
    4.2 North America Swine Flu Vaccine Consumption Value (2018-2029)
    4.3 Europe Swine Flu Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Swine Flu Vaccine Consumption Value (2018-2029)
    4.5 South America Swine Flu Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Swine Flu Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Swine Flu Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Swine Flu Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Swine Flu Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Swine Flu Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Swine Flu Vaccine Market Size by Country
        7.3.1 North America Swine Flu Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Swine Flu Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Swine Flu Vaccine Market Size by Country
        8.3.1 Europe Swine Flu Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Swine Flu Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Swine Flu Vaccine Market Size by Region
        9.3.1 Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Swine Flu Vaccine Market Size by Country
        10.3.1 South America Swine Flu Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Swine Flu Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Swine Flu Vaccine Market Size by Country
        11.3.1 Middle East & Africa Swine Flu Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Swine Flu Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Swine Flu Vaccine Market Drivers
    12.2 Swine Flu Vaccine Market Restraints
    12.3 Swine Flu Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Swine Flu Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Swine Flu Vaccine
    13.3 Swine Flu Vaccine Production Process
    13.4 Swine Flu Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Swine Flu Vaccine Typical Distributors
    14.3 Swine Flu Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Swine Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Swine Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Novartis Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis Major Business
    Table 5. Novartis Swine Flu Vaccine Product and Services
    Table 6. Novartis Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Novartis Recent Developments/Updates
    Table 8. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Limited Major Business
    Table 10. CSL Limited Swine Flu Vaccine Product and Services
    Table 11. CSL Limited Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Limited Recent Developments/Updates
    Table 13. Zydus Cadila Basic Information, Manufacturing Base and Competitors
    Table 14. Zydus Cadila Major Business
    Table 15. Zydus Cadila Swine Flu Vaccine Product and Services
    Table 16. Zydus Cadila Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Zydus Cadila Recent Developments/Updates
    Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 19. AstraZeneca Major Business
    Table 20. AstraZeneca Swine Flu Vaccine Product and Services
    Table 21. AstraZeneca Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. AstraZeneca Recent Developments/Updates
    Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 24. GlaxoSmithKline Major Business
    Table 25. GlaxoSmithKline Swine Flu Vaccine Product and Services
    Table 26. GlaxoSmithKline Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. GlaxoSmithKline Recent Developments/Updates
    Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 29. Sanofi Major Business
    Table 30. Sanofi Swine Flu Vaccine Product and Services
    Table 31. Sanofi Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Sanofi Recent Developments/Updates
    Table 33. Baxter Basic Information, Manufacturing Base and Competitors
    Table 34. Baxter Major Business
    Table 35. Baxter Swine Flu Vaccine Product and Services
    Table 36. Baxter Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Baxter Recent Developments/Updates
    Table 38. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
    Table 39. Sinovac Biotech Major Business
    Table 40. Sinovac Biotech Swine Flu Vaccine Product and Services
    Table 41. Sinovac Biotech Swine Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Sinovac Biotech Recent Developments/Updates
    Table 43. Global Swine Flu Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Dose)
    Table 44. Global Swine Flu Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 45. Global Swine Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 46. Market Position of Manufacturers in Swine Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 47. Head Office and Swine Flu Vaccine Production Site of Key Manufacturer
    Table 48. Swine Flu Vaccine Market: Company Product Type Footprint
    Table 49. Swine Flu Vaccine Market: Company Product Application Footprint
    Table 50. Swine Flu Vaccine New Market Entrants and Barriers to Market Entry
    Table 51. Swine Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Swine Flu Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 53. Global Swine Flu Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 54. Global Swine Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 55. Global Swine Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 56. Global Swine Flu Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 57. Global Swine Flu Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 58. Global Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 59. Global Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 60. Global Swine Flu Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 61. Global Swine Flu Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 62. Global Swine Flu Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 63. Global Swine Flu Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 64. Global Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 65. Global Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 66. Global Swine Flu Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. Global Swine Flu Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. Global Swine Flu Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 69. Global Swine Flu Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 70. North America Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 71. North America Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 72. North America Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 73. North America Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 74. North America Swine Flu Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 75. North America Swine Flu Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 76. North America Swine Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 77. North America Swine Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 78. Europe Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 79. Europe Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 80. Europe Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 81. Europe Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 82. Europe Swine Flu Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 83. Europe Swine Flu Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 84. Europe Swine Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Swine Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 87. Asia-Pacific Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 88. Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 89. Asia-Pacific Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 90. Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 91. Asia-Pacific Swine Flu Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 92. Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 93. Asia-Pacific Swine Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 94. South America Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 95. South America Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 96. South America Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 97. South America Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 98. South America Swine Flu Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 99. South America Swine Flu Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 100. South America Swine Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 101. South America Swine Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 103. Middle East & Africa Swine Flu Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 104. Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 105. Middle East & Africa Swine Flu Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 106. Middle East & Africa Swine Flu Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 107. Middle East & Africa Swine Flu Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 108. Middle East & Africa Swine Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Swine Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 110. Swine Flu Vaccine Raw Material
    Table 111. Key Manufacturers of Swine Flu Vaccine Raw Materials
    Table 112. Swine Flu Vaccine Typical Distributors
    Table 113. Swine Flu Vaccine Typical Customers
List of Figures
    Figure 1. Swine Flu Vaccine Picture
    Figure 2. Global Swine Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Swine Flu Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Intradermal Vaccination Examples
    Figure 5. Intramuscular Vaccination Examples
    Figure 6. Subcutaneous Vaccination Examples
    Figure 7. Others Examples
    Figure 8. Global Swine Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Swine Flu Vaccine Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Pharmacies Examples
    Figure 11. Retail Pharmacies Examples
    Figure 12. Online Pharmacies Examples
    Figure 13. Clinic And Vaccination Centers Examples
    Figure 14. Global Swine Flu Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Swine Flu Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Swine Flu Vaccine Sales Quantity (2018-2029) & (K Dose)
    Figure 17. Global Swine Flu Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 18. Global Swine Flu Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 19. Global Swine Flu Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 20. Producer Shipments of Swine Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 21. Top 3 Swine Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Top 6 Swine Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Global Swine Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 24. Global Swine Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 25. North America Swine Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Europe Swine Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Asia-Pacific Swine Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 28. South America Swine Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 29. Middle East & Africa Swine Flu Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 30. Global Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 31. Global Swine Flu Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 32. Global Swine Flu Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 33. Global Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 34. Global Swine Flu Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 35. Global Swine Flu Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 36. North America Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 37. North America Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 38. North America Swine Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 39. North America Swine Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 40. United States Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Canada Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Mexico Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Europe Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 44. Europe Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 45. Europe Swine Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 46. Europe Swine Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 47. Germany Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. France Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. United Kingdom Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Russia Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Italy Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 53. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 54. Asia-Pacific Swine Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 55. Asia-Pacific Swine Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 56. China Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Japan Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Korea Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. India Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Southeast Asia Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Australia Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. South America Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 63. South America Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 64. South America Swine Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 65. South America Swine Flu Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 66. Brazil Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Argentina Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 69. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 70. Middle East & Africa Swine Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 71. Middle East & Africa Swine Flu Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 72. Turkey Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Egypt Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Saudi Arabia Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. South Africa Swine Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. Swine Flu Vaccine Market Drivers
    Figure 77. Swine Flu Vaccine Market Restraints
    Figure 78. Swine Flu Vaccine Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Swine Flu Vaccine in 2022
    Figure 81. Manufacturing Process Analysis of Swine Flu Vaccine
    Figure 82. Swine Flu Vaccine Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
CSL Limited
Zydus Cadila
AstraZeneca
GlaxoSmithKline
Sanofi
Baxter
Sinovac Biotech

Related Reports

Global Swine Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Swine Flu Vaccine Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Pharma & Healthcare

The global Swine Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Swine Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Swine Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Swine Flu Vaccine market size was valued at USD 1580.5 million in 2023 and is forecast to a readjusted size of USD 2321.5 million by 2030 with a CAGR of 5.6% during review period.

Global Swine Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Global Swine Flu Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Swine Flu Vaccine market size is expected to reach $ 2321.5 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>